• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种含当代巴西毒株的灭活疫苗在小鼠体内的免疫原性

Immunogenicity of an Inactivated Vaccine with a Contemporary Brazilian Strain in Mice.

作者信息

Barbosa Amanda de Oliveira, Gava Danielle, Tochetto Caroline, Ribeiro Leonardo Clasen, Bastos Ana Paula Almeida, Morés Marcos Antônio Zanella, Schaefer Rejane, de Lima Marcelo

机构信息

Laboratório de Virologia e Imunologia, Universidade Federal de Pelotas, Capão do Leão 96160-000, RS, Brazil.

Embrapa Suínos e Aves, BR 153, Km 110, Distrito de Tamanduá, Concordia 89715-899, SC, Brazil.

出版信息

Vaccines (Basel). 2024 Jul 26;12(8):845. doi: 10.3390/vaccines12080845.

DOI:10.3390/vaccines12080845
PMID:39203971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11358955/
Abstract

(SVA) is a picornavirus that is endemic in swine, causing a vesicular disease clinically indistinguishable from other vesicular diseases, like foot-and-mouth disease. The widespread viral circulation, constant evolution, and economic losses caused to the swine industry emphasize the need for measures to control the agent. In this study, we evaluated the immunogenicity of a whole-virus-inactivated vaccine using a representative contemporary Brazilian SVA strain in Balb/ByJ mice. The animals were vaccinated with two doses by an intramuscular route. The humoral response induced by the vaccination was evaluated by an in-house ELISA assay for IgG detection. The cellular response was assessed by flow cytometry after in vitro SVA stimulation in splenocyte cultures from vaccinated and non-vaccinated groups. Protection against SVA was assessed in the experimental groups following an oral challenge with the homologous virus. The vaccination induced high levels of IgG antibodies and the proliferation of CD45R/B220sIgM, CD3eCD69, and CD3eCD4CD44CD62L cells. These results indicate the immunogenicity and safety of the vaccine formulation in a murine model and the induction of humoral and cellular response against SVA.

摘要

猪水疱病病毒(SVA)是一种在猪群中流行的小RNA病毒,可引发一种临床上与其他水疱病难以区分的水疱病,如口蹄疫。病毒的广泛传播、不断进化以及给养猪业造成的经济损失凸显了采取措施控制该病原体的必要性。在本研究中,我们使用一株具有代表性的当代巴西SVA毒株,在Balb/ByJ小鼠中评估了全病毒灭活疫苗的免疫原性。通过肌肉注射途径给动物接种两剂疫苗。通过一种用于检测IgG的内部ELISA试验评估疫苗接种诱导的体液反应。在对接种组和未接种组的脾细胞培养物进行体外SVA刺激后,通过流式细胞术评估细胞反应。在用同源病毒进行口服攻毒后,在实验组中评估对SVA的保护作用。疫苗接种诱导了高水平的IgG抗体以及CD45R/B220sIgM、CD3eCD69和CD3eCD4CD44CD62L细胞的增殖。这些结果表明该疫苗制剂在小鼠模型中的免疫原性和安全性,以及诱导了针对SVA的体液和细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/5e39feb45710/vaccines-12-00845-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/2b3758db7133/vaccines-12-00845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/b393b6c49c52/vaccines-12-00845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/8faa0449c9be/vaccines-12-00845-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/5e39feb45710/vaccines-12-00845-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/2b3758db7133/vaccines-12-00845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/b393b6c49c52/vaccines-12-00845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/8faa0449c9be/vaccines-12-00845-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba51/11358955/5e39feb45710/vaccines-12-00845-g004.jpg

相似文献

1
Immunogenicity of an Inactivated Vaccine with a Contemporary Brazilian Strain in Mice.一种含当代巴西毒株的灭活疫苗在小鼠体内的免疫原性
Vaccines (Basel). 2024 Jul 26;12(8):845. doi: 10.3390/vaccines12080845.
2
Evaluation of immunogenicity and protective efficacy of a novel Senecavirus A strain-based inactivated vaccine in mice.新型A组赛尼卡病毒株灭活疫苗在小鼠体内的免疫原性和保护效力评估
Res Vet Sci. 2021 Dec 20;142:133-140. doi: 10.1016/j.rvsc.2021.12.010.
3
A Novel Live Attenuated Vaccine Candidate Protects Against Heterologous Challenge.一种新型减毒活疫苗候选物可预防异源挑战。
Front Immunol. 2019 Nov 26;10:2660. doi: 10.3389/fimmu.2019.02660. eCollection 2019.
4
Development and Evaluation of a Competitive Enzyme-Linked Immunosorbent Assay Based on Swine Monoclonal Antibodies for Detecting Neutralizing Antibodies against Senecavirus A.基于猪源单克隆抗体的抗塞尼卡病毒 A 中和抗体竞争性酶联免疫吸附试验的建立与评价
Microbiol Spectr. 2023 Jun 15;11(3):e0459922. doi: 10.1128/spectrum.04599-22. Epub 2023 Apr 10.
5
Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs.辅助筛选小鼠中的塞尼卡病毒 A 灭活疫苗并评估其在猪中的免疫原性。
BMC Vet Res. 2024 Mar 6;20(1):82. doi: 10.1186/s12917-024-03949-5.
6
Adaptive Immune Responses following Senecavirus A Infection in Pigs.猪感染A组赛尼卡病毒后的适应性免疫反应。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01717-17. Print 2018 Feb 1.
7
Potent Protective Immune Responses to Induced by Virus-Like Particle Vaccine in Pigs.猪用病毒样颗粒疫苗诱导产生的强效保护性免疫反应。
Vaccines (Basel). 2020 Sep 15;8(3):532. doi: 10.3390/vaccines8030532.
8
Efficacy of an inactivated Senecavirus A vaccine in weaned pigs and mature sows.灭活塞尼卡病毒 A 疫苗对断奶仔猪和成年母猪的效力。
Vaccine. 2022 Mar 15;40(12):1747-1754. doi: 10.1016/j.vaccine.2022.02.018. Epub 2022 Feb 16.
9
A nanoparticle vaccine based on the VP1 and VP2 structural proteins of Senecavirus A induces robust protective immune responses.一种基于塞内卡病毒 A 的 VP1 和 VP2 结构蛋白的纳米颗粒疫苗可诱导强烈的保护性免疫应答。
Vet Microbiol. 2024 Sep;296:110198. doi: 10.1016/j.vetmic.2024.110198. Epub 2024 Jul 25.
10
Preliminary Evaluation of Protective Efficacy of Inactivated Senecavirus A on Pigs.猪用灭活A型赛尼卡病毒防护效果的初步评估
Life (Basel). 2021 Feb 18;11(2):157. doi: 10.3390/life11020157.

引用本文的文献

1
Using reverse genetics tool for study of Senecavirus A: pros and cons.利用反向遗传学工具研究A组赛尼卡病毒:利弊
Front Vet Sci. 2025 Apr 2;12:1546709. doi: 10.3389/fvets.2025.1546709. eCollection 2025.

本文引用的文献

1
Construction and immunogenicity of Senecavirus A virus-like particle vaccine with adjuvant.含佐剂的A组赛尼卡病毒样颗粒疫苗的构建及免疫原性
Vet Microbiol. 2024 Feb;289:109971. doi: 10.1016/j.vetmic.2023.109971. Epub 2023 Dec 30.
2
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine.免疫小鼠多价病毒体流感疫苗的免疫谱。
Virol J. 2023 Aug 21;20(1):187. doi: 10.1186/s12985-023-02158-0.
3
Evolutionary dynamics and adaptive analysis of Seneca Valley virus.塞尼卡谷病毒的进化动态与适应性分析。
Infect Genet Evol. 2023 Sep;113:105488. doi: 10.1016/j.meegid.2023.105488. Epub 2023 Aug 7.
4
PARNAS: Objectively Selecting the Most Representative Taxa on a Phylogeny.PARNAS:在系统发育树上客观选择最具代表性的分类群。
Syst Biol. 2023 Nov 1;72(5):1052-1063. doi: 10.1093/sysbio/syad028.
5
Identification of B-cell epitopes on structural proteins VP1 and VP2 of Senecavirus A and development of a multi-epitope recombinant protein vaccine.鉴定塞尼卡病毒 A 结构蛋白 VP1 和 VP2 上的 B 细胞表位及多表位重组蛋白疫苗的研制。
Virology. 2023 May;582:48-56. doi: 10.1016/j.virol.2023.03.015. Epub 2023 Mar 30.
6
The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression.共表达猪捷申病毒A VP2蛋白的重组伪狂犬病病毒的构建及免疫原性分析
Microbiol Spectr. 2023 Mar 28;11(2):e0522922. doi: 10.1128/spectrum.05229-22.
7
The third wave of Seneca Valley virus outbreaks in pig herds in southern Brazil.巴西南部猪群中塞内卡山谷病毒的第三次爆发浪潮。
Braz J Microbiol. 2022 Sep;53(3):1701-1706. doi: 10.1007/s42770-022-00767-5. Epub 2022 May 12.
8
Evaluation of Immunoreactivity and Protection Efficacy of Seneca Valley Virus Inactivated Vaccine in Finishing Pigs Based on Screening of Inactivated Agents and Adjuvants.基于灭活剂和佐剂筛选的猪用塞内卡山谷病毒灭活疫苗免疫反应性及保护效力评估
Vaccines (Basel). 2022 Apr 18;10(4):631. doi: 10.3390/vaccines10040631.
9
Efficacy of an inactivated Senecavirus A vaccine in weaned pigs and mature sows.灭活塞尼卡病毒 A 疫苗对断奶仔猪和成年母猪的效力。
Vaccine. 2022 Mar 15;40(12):1747-1754. doi: 10.1016/j.vaccine.2022.02.018. Epub 2022 Feb 16.
10
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.传染病疫苗技术与平台:当前进展、挑战与机遇
Vaccines (Basel). 2021 Dec 16;9(12):1490. doi: 10.3390/vaccines9121490.